Skip to content
2000
Volume 19, Issue 23
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

This review presents a general overview of the subtype-selective dopamine receptor radioligands for in vivo imaging of dopamine receptor expression by positron emission tomography (PET). Besides the 11C- and 18F-labeled radioligands which are already in clinical use, a summary of subtype-selective radioligands which had been studied in vitro and in vivo is provided, which shines light onto the current status and recent developments in this field of radiopharmaceutical research.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/092986712802002518
2012-08-01
2025-09-27
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/092986712802002518
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test